Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea
Top Cited Papers
Open Access
- 20 April 2011
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (12), 1592-1598
- https://doi.org/10.1200/jco.2010.31.5200
Abstract
Purpose To further clarify the relationship between total cholesterol and cancer, which remains unclear. Methods We prospectively examined the association between total cholesterol and site-specific and all-cancer incidence among 1,189,719 Korean adults enrolled in the National Health Insurance Corporation who underwent a standardized biennial medical examination in 1992 to 1995 and were observed for 14 years until cancer diagnosis or death. Results Over follow-up, 53,944 men and 24,475 women were diagnosed with a primary cancer. Compared with levels less than 160 mg/dL, high total cholesterol (≥ 240 mg/dL) was positively associated with prostate cancer (hazard ratio [HR], 1.24; 95% CI, 1.07 to 1.44; P trend = .001) and colon cancer (HR, 1.12; 95% CI, 1.00 to 1.25; P trend = .05) in men and breast cancer in women (HR, 1.17; 95% CI, 1.03 to 1.33; P trend = .03). Higher total cholesterol was associated with a lower incidence of liver cancer (men: HR, 0.42; 95% CI, 0.38 to 0.45; P trend < .001; women: HR, 0.32; 95% CI, 0.27 to 0.39; P trend < .001), stomach cancer (men: HR, 0.87; 95% CI, 0.82 to 0.93; P trend ≤ .001; women: HR, 0.86; 95% CI, 0.77 to 0.97; P trend = .06), and, in men, lung cancer (HR, 0.89; 95% CI, 0.82 to 0.96; P trend < .001). Results for liver cancer were slightly attenuated after additional adjustment for liver enzyme levels and hepatitis B surface antigen status (men: HR, 0.60; P trend < .001; women: HR, 0.46; P trend = .003) and exclusion of the first 10 years of follow-up (men: HR, 0.59; P trend < .001; women: HR, 0.44; P trend < .001). Total cholesterol was inversely associated with all-cancer incidence in both men (HR, 0.84; 95% CI, 0.81 to 0.86; P trend < .001) and women (HR, 0.91; 95% CI, 0.87 to 0.95; P trend < .001), but these associations were attenuated after excluding incident liver cancers (men: HR, 0.95; P trend < .001; women: HR, 0.98; P trend = .32). Conclusion In this large prospective study, we found that total cholesterol was associated with the risk of several different cancers, although these relationships differed markedly by cancer site.Keywords
This publication has 39 references indexed in Scilit:
- Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialCancer Epidemiology, Biomarkers & Prevention, 2009
- Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohortCancer Causes & Control, 2009
- Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up studyAnnals of Oncology, 2009
- Serum total cholesterol and the risk of breast cancer in postmenopausal Korean womenCancer Causes & Control, 2009
- Association between plasma cholesterol and prostate cancer in the PSA eraInternational Journal of Cancer, 2008
- Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002JAMA, 2005
- Epidemiology of Hepatitis C Virus in KoreaIntervirology, 2005
- Risk of Stomach Cancer in Association with Serum Cholesterol and Beta-LipoproteinActa Oncologica, 1988
- Risks of Cancer of the Colon and Rectum in Relation to Serum Cholesterol and Beta-LipoproteinThe New England Journal of Medicine, 1986